SPCX Investors Uncapped Potential vs GE Turnaround
SpaceX's SPCX debut fueled by momentum faces GE Aerospace's steady earnings machine. Investors grapple with spcx inve...
Which Is Better Index Funds Or Mutual Funds
Both funds offer diversification; index funds are passive and typically cheaper. This comparison highlights key differences to inform your choice.
24,304 articles
Charles Hoskinson Denies Retirement Rumors Fanning London
Cardano founder Charles Hoskinson publicly rejects retirement rumors that spread across social media and even reached...
Coinbase Structurally Superior to MSTR Bitcoin Play
Coinbase reports a resilient services business while MicroStrategy shoulders heavy bitcoin exposure and fixed costs a...
Missed Nvidia Run? SMH Holders Outsized 12-Month Returns
A broad semiconductor ETF beat Nvidia over the past year, reshaping how investors view AI-driven winners and the valu...
Elon Musk GROK AI Predicts XRP Rally by 2026
A new GROK AI forecast linked to Elon Musk projects XRP could surge to several dollars by 2026, contingent on regulat...
Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
TIAA’s Shares Advice Separating Identity From Title
TIAA’s CEO argues that leaders should rent the title, not own it, and invest in character traits that endure beyond a...
SpaceX Spacemobile Fall: Rocket Stocks Slump as Oil Spike Hits Markets
SpaceX, Rocket Lab, and AST SpaceMobile retreat as a China rocket milestone and an oil price spike pressure space-sto...
McConnell’s Absence Could Jeopardize GOP Defense Push Amid Iran Escalation
With Senate leadership sidelined, key defense funding plans face delay as Iran tensions intensify and midterms loom. ...
President Trump Sells Micron Stock, AI Bets Soar Higher
Public disclosures show surprising activity in major names, but smart investing hinges on fundamentals, risk, and a d...
Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status